Asthma biologic may reduce oral steroid useA new trial for AstraZeneca’s benralizumab shows promising results for severe asthma patients.
New adjunctive medication for eosinophilic asthmaFDA has approved mepolizumab for adjunctive maintenance treatment of severe asthma in patients 12 years of age and older with markers of eosinophilic asthma.
Stress-fighting proteins give new hope for asthma cure
Stress-fighting proteins give new hope for asthma cureNew research reveals that stress-busting proteins could open door to more effective asthma treatments and therapies.
Cesarean birth, early antibiotics alter immunityBabies born via cesarean delivery and those treated with antibiotics during the first year of life are at least 3 times more likely to develop eosinophilic esophagitis, according to a new study.